ERK1/2 is involved in BPA-induced upregulation of ERRγ, as shown by the significantly reduced upregulation of ERRγ and proliferation of breast cancer cells in the presence of an ERK1/2 inhibitor (Song et al. 2015). The gene discussed is MAPK3; the disease is breast carcinoma.